Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

(2018) Andrew M. Blumenfeld et al.   JOURNAL OF HEADACHE AND PAIN

Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary

(2017) Ariane K. Kawata et al.   HEADACHE

Family Impact of Migraine: Development of the Impact of Migraine on Partners and Adolescent Children (IMPAC) Scale

(2017) Richard B. Lipton et al.   HEADACHE

Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID)

(2017) Asha Hareendran et al.   Health and Quality of Life Outcomes

A Controlled Trial of Erenumab for Episodic Migraine

(2017) Peter J. Goadsby et al.   NEW ENGLAND JOURNAL OF MEDICINE

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program

(2016) Richard B Lipton et al.   CEPHALALGIA

Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches

(2016) Sally Mannix et al.   Health and Quality of Life Outcomes

Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study

(2016) Dawn C. Buse et al.   MAYO CLINIC PROCEEDINGS

Difficulties in work activities and the pervasive effect over disability in patients with episodic and chronic migraine

(2015) D. D’Amico et al.   NEUROLOGICAL SCIENCES

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine

(2014) Regina Rendas-Baum et al.   Health and Quality of Life Outcomes

What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients

(2013) Antonia FH Smelt et al.   CEPHALALGIA

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study

(2013) Daniel Serrano et al.   VALUE IN HEALTH

Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life

(2012) Dawn C. Buse et al.   MAYO CLINIC PROCEEDINGS

Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

(2010) AM Blumenfeld et al.   CEPHALALGIA

Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine

(2010) Min Yang et al.   CEPHALALGIA

Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

(2010) R. Malessa et al.   CURRENT MEDICAL RESEARCH AND OPINION

Minimal Important Differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) Version 2.1

(2009) JC Cole et al.   CEPHALALGIA

Direct Cost Burden Among Insured US Employees With Migraine

(2008) Kevin Hawkins et al.   HEADACHE